{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:33:41Z","timestamp":1740126821625,"version":"3.37.3"},"reference-count":33,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Planta Med"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The medicinal plant Bryophyllum pinnatum was previously shown to block oxytocin (OT)-induced signals in myometrial cells, consistent with its tocolytic effect observed in patients. OT activates not only OT receptors but also V1A receptors, two receptors with high receptor homology that are both expressed in the myometrium and play a crucial role in myometrial contraction signaling. We aimed to study the molecular pharmacology of B. pinnatum herbal preparations using specific receptor ligands, the human myometrial cell line hTERT-C3, and cell lines expressing recombinant human OT and V1A receptors.<\/jats:p><jats:p>We found that press juice from B. pinnatum (BPJ) inhibits both OT- and vasopressin (AVP)-induced intracellular calcium increases in hTERT-C3 myometrial cells. In additional assays performed with cells expressing recombinant receptors, BPJ also inhibited OT and V1A receptor-mediated signals with a similar potency (IC50 about 0.5\u2009mg\/mL). We further studied endogenous OT- and AVP-sensitive receptors in hTERT-C3 cells and found that OT and AVP stimulated those receptors with similar potency (EC50 of ~\u20091\u2009nM), suggesting expression of both receptor subtypes. This interpretation was corroborated by the antagonist potencies of atosiban and relcovaptan that we found. However, using qPCR, we almost exclusively found expression of OT receptors suggesting a pharmacological difference between recombinant OT receptors and native receptors expressed in hTERT-C3 cells.<\/jats:p><jats:p>In conclusion, we show that B. pinnatum inhibits both OT and AVP signaling, which may point beyond its tocolytic effects to other indications involving a disbalance in the vasopressinergic system.<\/jats:p>","DOI":"10.1055\/a-2303-9608","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:16:17Z","timestamp":1712794577000},"page":"757-765","source":"Crossref","is-referenced-by-count":0,"title":["Bryophyllum pinnatum Inhibits Oxytocin and Vasopressin Signaling in Myometrial Cells"],"prefix":"10.1055","volume":"90","author":[{"given":"Leonie","family":"Zurfluh","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauriane","family":"Duvaud","sequence":"additional","affiliation":[{"name":"Institute of Pharma Technology, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland FHNW, Muttenz, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejla","family":"Inci","sequence":"additional","affiliation":[{"name":"Institute of Pharma Technology, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland FHNW, Muttenz, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-6516","authenticated-orcid":false,"given":"Olivier","family":"Potterat","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4489-0952","authenticated-orcid":false,"given":"Ana Paula","family":"Sim\u00f5es-W\u00fcst","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-6863","authenticated-orcid":false,"given":"Johannes","family":"Mosbacher","sequence":"additional","affiliation":[{"name":"Institute of Pharma Technology, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland FHNW, Muttenz, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"ref1","first-page":"3","article-title":"Le genre Kalanchoe structure et d\u00e9finition","volume":"33","author":"B Descoings","year":"2006","journal-title":"J Bot Soc Bot France"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1177\/1934578X1701200847","article-title":"Bryophyllum pinnatum-reverse engineering of an anthroposophic herbal medicine","volume":"12","author":"M Hamburger","year":"2017","journal-title":"Nat Prod Commun"},{"volume-title":"Medicinal Plants of Nigeria","year":"1973","author":"R Agoha","key":"ref3"},{"key":"ref4","first-page":"364","article-title":"Bryophyllum pinnatum (Lam.) Kurz.: Phytochemical and pharmacological profile: A review","volume":"3","author":"A Kamboj","year":"2009","journal-title":"Pharmacogn Rev"},{"key":"ref5","first-page":"683","article-title":"Ein neuer Weg in der tokolytischen Therapie","volume":"34","author":"W Hassauer","year":"1985","journal-title":"Erfahrungsheilkunde"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000437154","article-title":"The application of Bryophyllum pinnatum preparations in obstetrics and gynaecology \u2013 a multicenter, prospective observational study","volume":"22","author":"K F\u00fcrer","year":"2015","journal-title":"Forsch Komplementmed"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2183756","DOI":"10.1080\/14767058.2023.2183756","article-title":"Prevention of spontaneous preterm delivery \u2013 an update on where we are today","volume":"36","author":"B Ahmed","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1471-0528.2006.01127.x","article-title":"Use of tocolytics: What is the benefit of gaining 48 hours for the fetus?","volume":"113","author":"G C Di Renzo","year":"2006","journal-title":"BJOG"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12978-015-0115-7","article-title":"Tocolysis for inhibiting preterm birth in extremely preterm birth, multiple gestations and in growth-restricted fetuses: A systematic review and meta-analysis","volume":"13","author":"C Miyazaki","year":"2016","journal-title":"Reprod Health"},{"issue":"08","key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014978.pub2","article-title":"Tocolytics for delaying preterm birth: A network meta-analysis (0924)","author":"A Wilson","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00404-019-05313-7","article-title":"Maintenance tocolysis: A reappraisal of clinical evidence","volume":"300","author":"P Stelzl","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejogrb.2022.01.006","article-title":"Do obstetric units adhere to the evidence-based national guideline? A Germany-wide survey on the current practice of initial tocolysis","volume":"270","author":"P Stelzl","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogrm.2010.05.001","article-title":"Drugs acting on the pregnant uterus","volume":"20","author":"S Arrowsmith","year":"2010","journal-title":"Obstet Gynaecol Reprod Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cophys.2019.10.006","article-title":"Oxytocin and vasopressin signalling and myometrial contraction","volume":"13","author":"S Arrowsmith","year":"2020","journal-title":"Curr Opin Physiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jne.12154","article-title":"Oxytocin: Its mechanism of action and receptor signalling in the myometrium","volume":"26","author":"S Arrowsmith","year":"2014","journal-title":"J Neuroendocrinol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1471-0528.1999.tb08112.x","article-title":"Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women","volume":"106","author":"M Akerlund","year":"1999","journal-title":"BJOG"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1124\/mol.116.106013","article-title":"Differential effects of oxytocin receptor antagonists, atosiban and nolasiban, on oxytocin receptor\u2013mediated signaling in human amnion and myometrium","volume":"91","author":"S H Kim","year":"2017","journal-title":"Mol Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0301-2115(03)00370-1","article-title":"Effect of Bryophyllum pinnatum versus fenoterol on uterine contractility","volume":"113","author":"B Gwehenberger","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1055\/a-0810-7704","article-title":"A bufadienolide-enriched fraction of Bryophyllum pinnatum inhibits human myometrial contractility in vitro","volume":"85","author":"S Santos","year":"2019","journal-title":"Planta Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-019-2711-5","article-title":"Bryophyllum pinnatum enhances the inhibitory effect of atosiban and nifedipine on human myometrial contractility: an in vitro study","volume":"19","author":"S Santos","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.phymed.2010.03.005","article-title":"Juice of Bryophyllum pinnatum (Lam.) inhibits oxytocin-induced increase of the intracellular calcium concentration in human myometrial cells","volume":"17","author":"A P Sim\u00f5es-W\u00fcst","year":"2010","journal-title":"Phytomedicine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fphar.2021.632986","article-title":"Bryophyllum pinnatum compounds inhibit oxytocin-induced signaling pathways in human myometrial cells","volume":"12","author":"S Santos","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1210\/jcem-70-4-1142","article-title":"Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors","volume":"70","author":"M Maggi","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0306-5456(00)00043-7","article-title":"Effectiveness and safety of the oxytocin antagonist atosiban versus \u03b2-adrenergic agonists in the treatment of preterm labour","volume":"108","author":"J Moutquin","year":"2001","journal-title":"BJOG"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1111\/j.1476-5381.2011.01552.x","article-title":"Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins","volume":"165","author":"A C Magalhaes","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"214.e211","DOI":"10.1016\/j.ajog.2017.04.036","article-title":"Novel oxytocin receptor variants in laboring women requiring high doses of oxytocin","volume":"217","author":"E L Reinl","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12881-019-0894-8","article-title":"Influence of oxytocin receptor single nucleotide sequence variants on contractility of human myometrium: An in vitro functional study","volume":"20","author":"F F\u00fceg","year":"2019","journal-title":"BMC Med Genet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2350-14-77","article-title":"Sequence variants in oxytocin pathway genes and preterm birth: A candidate gene association study","volume":"14","author":"J Kim","year":"2013","journal-title":"BMC Med Genet"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1471-0528.1979.tb10794.x","article-title":"Primary dysmenorrhoea and vasopressin","volume":"86","author":"M \u00c5kerlund","year":"1979","journal-title":"BJOG"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3109\/00016348409156715","article-title":"Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea","volume":"63","author":"P Str\u00f6mberg","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1021\/acs.jmedchem.9b01478","article-title":"Discovery of balovaptan, a vasopressin 1a receptor antagonist for the treatment of autism spectrum disorder","volume":"63","author":"P Schnider","year":"2020","journal-title":"J Med Chem"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1095\/biolreprod67.2.506","article-title":"Telomerase immortalization of human myometrial cells","volume":"67","author":"J Condon","year":"2002","journal-title":"Biol Reprod"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-004-3118-8","article-title":"DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells","volume":"72","author":"A P Sim\u00f5es-W\u00fcst","year":"2005","journal-title":"J Neurooncol"}],"container-title":["Planta Medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2303-9608.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:04:08Z","timestamp":1730811848000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2303-9608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,8,5]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2303-9608","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0032-0943","1439-0221"],"issn-type":[{"type":"print","value":"0032-0943"},{"type":"electronic","value":"1439-0221"}],"subject":[],"published-other":{"date-parts":[[2024,4,10]]},"published":{"date-parts":[[2024,4,10]]}}}